Retia Medical CEO to Speak at
LSI - Life Science Intelligence™ Emerging Medtech Summit
Retia Medical CEO Marc Zemel has been selected to present LSI - Life Science Intelligence™ Emerging Medtech Summit, March 20-23, 2023, in Dana Point, CA. He will provide an update on Retia Medical's progress and the rapid growth the company has been experiencing in the adoption of our Argos system.
Based in White Plains Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients.
|